Boston Scientific (BSX) Com Stk US $0.01
Sell:$95.48Buy:$95.49
$1.61
(1.71%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$95.48
Buy:$95.49
Change:$1.61
(1.71%)
$1.61
(1.71%)Prices delayed by at least 15 minutes
Sell:$95.48
Buy:$95.49
Change:$1.61
(1.71%)
$1.61
(1.71%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 March 2025 | Emily WoodworthChief Accounting Officer | Sell Option/Award related | 482 | $104.63 | $50,431.66 | 432 |
| 3 March 2025 | Emily WoodworthChief Accounting Officer | Sell Regular sell transaction (market) | 7,149 | $104.97 | $750,464.85 | 914 |
| 1 March 2025 | Emily WoodworthChief Accounting Officer | Sell Tax related | 355 | $103.79 | $36,845.45 | 2,114 |
| 28 February 2025 | Emily WoodworthChief Accounting Officer | Sell Regular sell transaction (market) | 9,887 | $101.13 | $999,872.31 | 1,632 |
| 25 February 2025 | Jeffrey B (Jeff) MirvissOther President | Sell Regular sell transaction (market) | 2,688 | $104.00 | $279,552.00 | 25,766 |
| 24 February 2025 | Ellen M ZaneDirector | Sell Regular sell transaction (market) | 13,586 | $104.23 | $1,416,133.99 | 34,944 |
| 24 February 2025 | Jeffrey B (Jeff) MirvissOther President | Sell Regular sell transaction (market) | 4,675 | $104.25 | $487,368.75 | 28,454 |
| 21 February 2025 | Vance Ronald BrownCompany Secretary | Sell Regular sell transaction (market) | 4,826 | $104.64 | $504,992.64 | 45,845 |
| 19 February 2025 | Daniel J (Dan) BrennanCFO | Sell Option/Award related | 67,333 | $105.24 | $7,086,111.45 | 225,808 |
| 19 February 2025 | Jeffrey B (Jeff) MirvissOther President | Sell Option/Award related | 1,510 | $105.35 | $159,078.50 | 33,129 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 5 November 2024 | Michael F MahoneyChairman/CEO | Sell Regular sell transaction (market) | 160,182 | $84.74 | $13,573,742.59 | 1,521,205 |
| 5 September 2024 | Michael F MahoneyChairman/CEO | Sell Regular sell transaction (market) | 162,777 | $81.17 | $13,212,543.98 | 1,622,987 |
| 7 October 2024 | Joseph Michael FitzgeraldOther President | Sell Regular sell transaction (market) | 132,527 | $85.00 | $11,264,887.77 | 160,467 |
| 19 February 2025 | Daniel J (Dan) BrennanCFO | Sell Option/Award related | 67,333 | $105.24 | $7,086,111.45 | 225,808 |
| 7 October 2024 | Michael F MahoneyChairman/CEO | Sell Regular sell transaction (market) | 82,085 | $84.94 | $6,972,431.24 | 1,572,096 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.